dyer@spdcc.COM (Steve Dyer) (01/18/90)
Venlafexine is a new antidepressant drug of novel chemical structure with
similar effects on monoamine reuptake as the tricyclic antidepressants.
It appears to be dissimilar to this class of drug in that it has few
receptor actions other than to inhibit monoamine reuptake. This appears
promising, because most tricyclics have a variety of actions at other
receptors, including antihistaminic and anticholinergic side effects which
can be quite annoying.
I don't know a whole lot about it; as you say, it's quite new and under
investigation. If I find out anything more, I'll let you know.
--
Steve Dyer
dyer@ursa-major.spdcc.com aka {ima,harvard,rayssd,linus,m2c}!spdcc!dyer
dyer@arktouros.mit.edu, dyer@hstbme.mit.edu